Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer

Dorit Pud, Gil Har-Zahav, Yael Laitman, Tami Rubinek, Adva Yeheskel, Sarah Ben-Ami, Bella Kaufman, Eitan Friedman, Zvi Symon, Ido Wolf

University of Haifa, Tel Aviv University

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences